EDITORIAL
Published on 02 Jul 2020
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy
doi 10.3389/fphar.2020.01001
- 1,499 views
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/ Pathways to Increase Treatment Efficacy
Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/ Pathways to Increase Treatment Efficacy
26k
Total downloads
131k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 14 May 2020
Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
doi 10.3389/fpsyt.2020.00369
- 23,813 views
- 31 citations
MINI REVIEW
Accepted on 15 May 2019
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches
doi 10.3389/fphar.2019.00617
- 4,798 views
- 23 citations
REVIEW
Published on 16 Apr 2019
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
doi 10.3389/fphar.2019.00402
- 18,159 views
- 43 citations
SYSTEMATIC REVIEW
Published on 26 Feb 2019
Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review
doi 10.3389/fpsyt.2019.00067
- 10,501 views
- 81 citations
REVIEW
Published on 10 Jan 2019
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review
doi 10.3389/fphar.2018.01542
- 3,763 views
- 26 citations
REVIEW
Published on 09 Jan 2019
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
doi 10.3389/fpsyt.2018.00702
- 18,680 views
- 51 citations
ORIGINAL RESEARCH
Published on 07 Dec 2018
Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome
doi 10.3389/fpsyt.2018.00647
- 3,317 views
- 25 citations
CORRECTION
Published on 04 Dec 2018
Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
doi 10.3389/fphar.2018.01417
- 871 views
- 1 citation
REVIEW
Published on 18 Oct 2018
Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
doi 10.3389/fphar.2018.01172
- 4,143 views
- 10 citations
SYSTEMATIC REVIEW
Published on 15 Oct 2018
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review
doi 10.3389/fphar.2018.01040
- 8,092 views
- 36 citations
REVIEW
Published on 26 Sep 2018
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
doi 10.3389/fphar.2018.01049
- 9,229 views
- 27 citations
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Psychiatry
- 3.2 impact factor
- 6.2 citescore
Impact
- 131kTopic views
- 103kArticle views
- 26kArticle downloads